Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2011; 17(14): 1807-1816
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1807
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1807
Figure 1 Screening and prevalence rates for hepatitis B and hepatitis C, liver disease prevalence, and hepatitis B vaccinations among human immunodeficiency virus-infected individuals; Adult/adolescent Spectrum of human immunodeficiency virus disease project, 11 U.
S. metropolitan areas; 1998-2004.HCV: Hepatitis C virus; HBV: Hepatitis B virus.
Figure 2 Cumulative prevalence of hepatitis C virus, chronic hepatitis B virus , liver disease, and overlapping diagnoses among 29 490 individuals; Adult/adolescent Spectrum of human immunodeficiency virus-related Diseases Project, 11 U.
S. metropolitan areas; 1998-2004. HCV: Hepatitis C virus; HBV: Hepatitis B virus.
Figure 3 Cumulative death rate per 100 persons and 95% CI for hepatitis C virus , chronic hepatitis B virus , liver disease , and overlapping diagnoses among 29 490 individuals; Adult/adolescent spectrum of human immunodeficiency virus-related diseases project, 11 U.
S. HCV: Hepatitis C virus; HBV: Hepatitis B virus; LD: Liver disease.
- Citation: Buskin SE, Barash EA, Scott JD, Aboulafia DM, Wood RW. Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals. World J Gastroenterol 2011; 17(14): 1807-1816
- URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1807.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1807